InvestorsHub Logo
icon url

lightrock

10/08/19 12:19 PM

#26150 RE: fluteman #26147

Well, most biotech stuff fails, so if you make a podcast or a blog or something, it is easy to look like a genius.
icon url

pijoe

10/08/19 12:29 PM

#26151 RE: fluteman #26147

Your last point is what AF wants. Dont let him win.
icon url

RobotDroid

10/08/19 12:36 PM

#26153 RE: fluteman #26147

Every biotech I have been in af was dead wrong on. His track record is not that good.
icon url

greens12

10/08/19 12:38 PM

#26154 RE: fluteman #26147

He gets paid by shortsellers to write articles that are based on opinions by a person who has no medical or science back round.So that means he is not qualified and that is a well known fact. Ask yourself this....should i trust someone like that after he has done this before and been wrong with PUMA and many more.Or do i pay attention to the stats that have been posted on why the Endpoint has already been met but trial must continue all the way to 298 event and IDMC says continue even though they shut down many other trials on futility, and CVM insiders buying and holding.





CVM